Davide Zocco

Bringing any nanoparticle-based therapy to life as Head of Commercial Development, Site Head at Lonza

Siena, Tuscany, Italy

About

I am a detail-oriented, innovative and passionate PhD scientist with 12 years of research experience in signaling pathways and tissue responses in chronic inflammatory diseases and cancer. My goal is to provide solutions to unanswered scientific questions and technical challenges that would lead to better therapies and cost-effective diagnostic strategies. Specialties: Molecular and Companion Diagnostics (EV-based), Signaling mechanisms in chronic inflammatory arthritis and cancer, drug development, target discovery and validation, technology transfer and innovation.

Experience

  • Lonza (Full-time · 5 yrs 10 mos)
    • Head of Commercial Development Exosomes & mRNA-LNPs and Site Head
      Jul 2025 - Present · 1 yr

    • Head of Exosomes Development and Site Head
      Dec 2021 - Oct 2025 · 3 yrs 11 mos

    • Senior Manager
      Sep 2020 - Dec 2021 · 1 yr 4 mos

  • Exosomics (8 yrs 5 mos)
    • Chief Technology Officer
      May 2019 - Nov 2021 · 2 yrs 7 mos

    • Director Of Research Development
      Jan 2018 - May 2019 · 1 yr 5 mos

    • Head of Molecular Diagnostics
      Jul 2013 - Jan 2018 · 4 yrs 7 mos

      To develop standard operating procedures for sample collection, processing and analysis. Establish and manage external collaborations in the field of companion diagnostics and molecular diagnostics. Develop molecular tools for the analysis of vesicle based biomarkers (miRNA, mRNA and DNA). Design and assemble a kit for the detection of biomarkers for monitoring therapeutic responses and mechanisms of acquired resistance to next-generation cancer therapies.

  • Postdoctoral Research Fellow at Harvard University
    Jul 2009 - Jul 2013 · 4 yrs 1 mo

    Research Experience: To investigate the tissue-protective effects of a new class of small-molecule inhibitors of the enzyme prolyl-tRNA-synthetase (EPRS) in vitro and in vivo models of inflammatory arthritis. Also, to elucidate basics and novel molecular mechanisms downstream of the amino acid starvation response pathway in fibroblast, epithelial and cancer cells. Teaching and Leading Experience: Throughout my postdoctoral research training in the Whitman lab, I directly supervised summer students and staff members. In spring 2011 and 2012, I have been the director of the Harvard School of Dental Medicine nanocourse: "Inflammation and Fibrosis in Health and Disease". Learning Experience: I harnessed great scientific insights from the bounty of world-class scientific talks, nanocourses and conferences of Harvard Medical School, Harvard University and MIT. Given my interest in entrepreneurship, management and business, I actively complemented my scientific background with solid business knowledge by attending management and economics classes at Harvard University.

  • University College Dublin (3 yrs 10 mos)
    • PhD Research Associate
      Feb 2009 - Jul 2009 · 6 mos

      To support and supervise postgraduate student; to publish scientific results in peer-review journals

    • PhD Graduate
      Oct 2005 - Feb 2009 · 3 yrs 5 mos

      Post-graduate student investigating signalling pathways involved in cancer and rheumatoid arthritis

  • Master of Science in Industrial Biotechnology at Università degli Studi di Milano-Bicocca
    Sep 1999 - Apr 2005 · 5 yrs 8 mos

    From 1999 to 2003 I have attended lectures at the department of Biotechnology and Biosciences to become a Bachelor of Science in Biotechnology. From 2003 to 2005 I have been involved in a research project focused on optimising non-conventional yeasts for the production of organic acids and heterologous proteins. In April 2005 I became Master of Science in Industrial Biotechnology. Final Grade: 110/110 cum laude (with Hons.)